Robert J. Klaassen
401 Smyth Road
Ottawa, ON, Canada
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications
Steroid Responsiveness and Clinical Outcomes in Diamond-Blackfan Anemia: Analysis From the Canadian Inherited Marrow Failure Registry.
Journal: European journal of haematology
Published: March 02, 2026
Treatment Strategies and Outcomes in Pediatric Patients With Immune Thrombocytopenia Undergoing Surgical Procedures: A Multicenter Study.
Journal: Pediatric blood & cancer
Published: January 17, 2026
Outcomes of Dyskeratosis Congenita: Results From the Canadian Inherited Marrow Failure Registry.
Journal: Journal of pediatric hematology/oncology
Published: October 28, 2025
Expanding genetic landscape of inherited bone marrow failure syndromes: Insights from the Canadian Inherited Marrow Failure Registry (CIMFR) (2001-2023).
Journal: British journal of haematology
Published: September 30, 2025
Taking Care of the Caregivers: A Quality-of-Life Measure for the Parents of Children With Transfusion-Dependent Thalassemia.
Journal: Pediatric blood & cancer
Published: June 18, 2025
Heterozygous missense mutation of the fibrinogen gene associated with cryptogenic liver disease in a 15-months-old Canadian caucasian child.
Journal: Ultrastructural pathology
Published: December 31, 2024
Working toward international consensus defining pediatric "refractory ITP".
Journal: Blood advances
Published: December 17, 2024
Enhancing Engagement to Support Shared Decision Making Within Haemophilia: Development of Materials for People With Haemophilia, Caregivers and Healthcare Professionals.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: December 15, 2024
Splenic Embolization for Primary Immune Thrombocytopenia Complicated With Intracranial Hemorrhage-Case Report of 2 Patients.
Journal: Journal of pediatric hematology/oncology
Published: September 12, 2024
Early Engraftment and Immune Kinetics Following Allogeneic Transplant Using a Novel Reduced-Toxicity Transplant Strategy in Children/Adolescents with High-Risk Transfusion-Dependent Thalassemia: Early Results of the ThalFAbS Trial.
Journal: Transplantation and cellular therapy
Published: August 22, 2024
Last Updated: 09/26/2026